U.S. Pharma Stock News

Amcor plc has confirmed it will implement a previously approved 1-for-5 reverse stock split, effective after the close of trading on January 14, 2026, consolidating its approximately 2.30 billion outstanding ordinary shares into about 0.46 billion and proportionately adjusting authorized share capital, par value, CHESS Depositary Interests, and equity-based awards. The move simplifies Amcor's capital structure and lifts the per-share reference price, while cashing out fractional holdings and...

Relay Therapeutics (RLAY) just put fresh clinical data for its PI3K alpha inhibitor zovegalisib in front of oncologists at the San Antonio Breast Cancer Symposium, and the subset analysis immediately sharpened the stock’s risk reward profile. See our latest analysis for Relay Therapeutics. The zovegalisib update lands after a sharp rebound in sentiment, with a roughly 97 percent 90 day share price return and a 104 percent one year total shareholder return, even though the five year total...

Immunome (IMNM) just delivered a big one two for investors, first unveiling strong Phase 3 RINGSIDE data for varegacestat in desmoid tumors, then swiftly raising about $400 million through a follow on stock offering. See our latest analysis for Immunome. Those blockbuster Phase 3 results and the follow on raise have not gone unnoticed, with the share price climbing to $22.33 and delivering a 90 day share price return of about 120 percent, while the three year total shareholder return is...

T-Mobile US recently reinforced its market position by being named America’s Best Network, launching T-Satellite direct-to-cell service with Starlink, rolling out 5-year price-guaranteed plans, and expanding into fiber broadband while intensifying competitive pressure on rivals such as Verizon. Beneath the consumer-friendly promotions and disaster-resilience initiatives, T-Mobile’s ongoing 5G and fiber build-out highlights a push to deepen customer relationships across both mobile and home...

KBR (KBR) just slid about 5% after the Lake Charles LNG export project was suspended, a move that has sharpened investor focus on how much of the company’s future depends on big engineering work. See our latest analysis for KBR. The Lake Charles setback comes after a mixed stretch for the stock, with a 1 year to date share price return of around minus 30 percent and a 1 year total shareholder return of roughly minus 29 percent. At the same time, new defense and energy transition wins hint...

Caliber’s decision to tap StoneX Group (SNEX) as an institutional trading and custody partner for its Digital Asset Treasury strategy puts StoneX squarely in the path of growing institutional demand around blockchain linked reserves. See our latest analysis for StoneX Group. That backdrop helps explain why investors have been steadily re-rating StoneX, with the share price now at $98.07 and a strong year to date share price return of 46.8 percent, alongside a robust 5 year total shareholder...

Americold Realty Trust (COLD) has quietly staged a sharp rebound this month, even as its longer term returns remain deeply negative. That mix of short term strength and multi year pain is exactly what makes the stock interesting now. See our latest analysis for Americold Realty Trust. The recent 20.1% 1 month share price return to $12.57 has sparked some optimism, but it comes after a heavy 41.1% year to date share price decline and multi year total shareholder losses. This suggests sentiment...

Grand Canyon Education (LOPE) just posted revenue growth of about 10% in line with expectations, but its softer full year earnings guidance and lag versus peers quickly turned the spotlight to profitability. See our latest analysis for Grand Canyon Education. That cautious EPS outlook helps explain why, even with a solid 30 day share price return of 8.35 percent, Grand Canyon Education is still working off a 21.51 percent 90 day share price pullback. This leaves long term total shareholder...

Wondering if Constellation Energy at around $363 a share is still a smart buy after its massive run, or if you are turning up late to the party? This article examines whether the current price still stacks up against the company fundamentals. The stock has climbed about 6.7% over the last week and 2.8% over the past month, with an eye catching 50.0% year to date and 59.3% over the last year, on top of a 330.7% gain over three years. Recently, investors have been focused on Constellation...

Steady gains and what they might mean for investors Textron (TXT) has quietly put together a solid run, with the stock up about 10% over the past month and nearly 20% year to date, catching the attention of patient investors. See our latest analysis for Textron. The latest 10.3% 1 month share price return, combined with a 19.9% year to date share price gain and strong multi year total shareholder returns, suggests momentum is building as investors warm to Textron’s steady execution and modest...

Rezolute (RZLT) just released topline data from its pivotal Phase 3 sunRIZE trial in congenital hyperinsulinism, and the drug missed both primary and key secondary endpoints, forcing investors to quickly reassess the story. See our latest analysis for Rezolute. The setback helps explain why Rezolute’s 30 day share price return sits at around negative 72 percent even after a sharp short term rebound. The share price closed at 2.74 dollars, and while the three year total shareholder return is...

Wondering whether Chemours at around $12 is a bargain or a value trap? You are not alone, and this breakdown is designed to help you decide with a clear, valuation-first lens. Despite a tough longer-term picture, with the stock still down 29.0% over the past year and 55.1% over three years, it has shown some short-term life, rising 3.4% in the last week and 4.3% over the past month, even though it remains down 28.2% year to date. Recent moves have been shaped by ongoing headlines around...

NGL Energy Partners LP recently declared quarterly distributions for its 11.460% Class B and 11.369% Class C Floating Rate Cumulative Redeemable Perpetual Preferred Units, along with a US$14,618,325.21 cash distribution for its Class D Preferred Units, all payable on January 15, 2026 to holders of record on January 1, 2026. This comes as NGL Energy Partners has been benefiting from a very large upward revision in full-year earnings estimates and a higher Zacks Rank, signaling a shift in...

In December 2025, the state of Maryland selected ICF International as one of eight prime awardees on a US$300 million, nine-year Agile Digital Experience Product Transformation contract to modernize digital services across state and local agencies. This long-duration, statewide digital transformation vehicle underscores ICF’s role in overhauling legacy government systems using agile, human-centered design and enterprise architecture, potentially reinforcing its broader government technology...

CarMax, Inc. has already reported third-quarter 2025 results showing sales of US$150.63 million and net income of US$62.22 million, alongside ongoing share repurchases and multiple securities class action lawsuits alleging misleading disclosures around demand and its auto finance portfolio. Beyond weaker earnings, the combination of leadership transition, aggressive cost-cutting plans, and legal scrutiny raises fresh questions about the durability and quality of CarMax’s growth...

Permian Resources (PR) just kicked off a restructuring that shifts management and long-term holders from Class C to Class A shares under a new holding company, tightening alignment with everyday shareholders. See our latest analysis for Permian Resources. That backdrop helps explain why the latest holding company cleanup comes as the share price sits around $13.88, with near term share price momentum soft but long term total shareholder returns still very strong, suggesting sentiment is...

In recent weeks, Intuitive Surgical received expanded FDA clearance for its da Vinci Single Port system to perform three common general surgery procedures, inguinal hernia repair, cholecystectomy, and appendectomy, broadening the platform’s use beyond its earlier urology, colorectal, thoracic, and transoral indications. This wider procedural toolkit, combined with ongoing enhancements in digital and AI capabilities, meaningfully deepens the company’s role in everyday minimally invasive...

Seagate Technology Holdings (STX) just earned a spot in the Nasdaq 100, a milestone that typically boosts liquidity and visibility, and it comes as AI driven storage demand is already powering a strong run. See our latest analysis for Seagate Technology Holdings. All of this lands on top of an already powerful backdrop, with a roughly 230 percent year to date share price return and a more than fivefold three year total shareholder return suggesting momentum is still very much building rather...

In December 2025, The Western Union Company announced a new partnership with Deutsche Post to launch cross-border money transfer services across most Deutsche Post partner branches in Germany, with availability expected from the second quarter of 2026. This collaboration meaningfully broadens Western Union’s physical distribution in a key European remittance market, potentially reinforcing its push to blend retail access with its evolving digital and fintech offerings. Next, we’ll examine...

Global Ship Lease (GSL) has quietly turned into one of the stronger performers in shipping, with the stock climbing over the past year even as revenue and net income have both slipped. See our latest analysis for Global Ship Lease. That steady climb in the share price, now at $34.53, reflects investors warming to Global Ship Lease again, with a strong year to date share price return of 52.18 percent and a powerful 68.78 percent one year total shareholder return suggesting momentum is still...

Fresh analyst projections pointing to higher revenue have put Construction Partners (ROAD) back on investors radar, pairing upbeat expectations with a strong history of earnings growth and steadily improving free cash flow margins. See our latest analysis for Construction Partners. The share price has climbed to around $112, with a robust year to date share price return of roughly 28% and a standout three year total shareholder return above 300%, signaling momentum that investors clearly...

If you are wondering whether Amentum Holdings is still a smart place to put fresh money to work, you are not alone, and this article is going to tackle that value question head on. The stock has climbed 4.3% over the last week, 17.9% over the past month, and is now up 38.1% year to date, with a striking 51.0% gain over the last year, which naturally raises the question of whether the market is getting ahead of itself or just starting to catch up. Recent headlines have focused on Amentum...

If you are wondering whether BioMarin Pharmaceutical is a bargain or a value trap at around $60 a share, you are not alone, and this piece will walk through what the numbers actually say. After a long slide that has left the stock down about 9.7% over the past year and around 40.9% over three years, the recent 16.1% jump in the last week and 8.4% rise over the past month suggest sentiment might finally be turning. Much of this renewed interest has been driven by pipeline and regulatory...

Wondering if Travelers Companies is still attractively priced after its big run, or if the easy money has already been made? This breakdown will help you assess whether the current price still stacks up against its fundamentals. The stock has climbed to around $293.84, delivering 0.9% over the last week, 1.0% over the past month, and 22.0% year to date, with gains of 23.0% over 1 year, 65.3% over 3 years, and 133.6% over 5 years. Recent coverage has highlighted Travelers positioning in the...